None
Quote | VolitionRX Limited (NYSE:VNRX)
Last: | $0.63 |
---|---|
Change Percent: | -0.89% |
Open: | $0.6245 |
Close: | $0.63 |
High: | $0.6551 |
Low: | $0.6105 |
Volume: | 52,604 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | VolitionRX Limited (NYSE:VNRX)
VolitionRx Limited (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company focused on saving lives and improving outcomes for people and animals with life-altering diseases, has released a mid-year review that highlights significant milestones, such as the expansio...
VolitionRx Limited Issues Mid-Year Review Ahead of 2024 Annual Meeting PR Newswire HENDERSON, Nev. , June 27, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has issued a mid-year review to stockho...
Message Board Posts | VolitionRX Limited (NYSE:VNRX)
Subject | By | Source | When |
---|---|---|---|
Give me $2.50 !! $$ VNRX $$ | budgetthis | investorshub | 03/17/2023 5:36:03 PM |
whytestocks: $VNRX News Article - Life Sciences Virtual Investor Forum: Presentations Now Available | whytestocks | investorshangout | 03/10/2023 1:45:46 PM |
whytestocks: $VNRX News Article - VolitionRx Limited Schedules Full Year 2022 Earnings Conference Ca | whytestocks | investorshangout | 03/10/2023 1:40:47 PM |
whytestocks: $VNRX News Article - Life Sciences Virtual Investor Forum Agenda Announced for March 9t | whytestocks | investorshangout | 03/07/2023 6:20:47 PM |
whytestocks: $VNRX News Article - Volition Signs Global Supply Agreement for Nu.Q Vet Cancer Test | whytestocks | investorshangout | 10/20/2022 2:05:48 PM |
News, Short Squeeze, Breakout and More Instantly...
VolitionRx Limited (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company focused on saving lives and improving outcomes for people and animals with life-altering diseases, has released a mid-year review that highlights significant milestones, such as the expansio...
VolitionRx Limited Issues Mid-Year Review Ahead of 2024 Annual Meeting PR Newswire HENDERSON, Nev. , June 27, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has issued a mid-year review to stockho...
ORLANDO, FL / ACCESSWIRE / June 14, 2024 / RedChip Companies will air interviews with Nexalin Technology, Inc. (Nasdaq:NXL) ("Nexalin") and VolitionRX Limited (NYSE American:VNRX) ("Volition") on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturd...